South San Francisco, CA, United States of America

Marc Adler

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 13.1

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2017-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Exploring the Innovations of Marc Adler in Therapeutic Compounds

Introduction: Marc Adler, a talented inventor based in South San Francisco, CA, has made significant contributions to the field of pharmaceuticals with his groundbreaking inventions. With a strong background in chemistry and pharmacology, Marc's work has centered around developing novel therapeutic compounds to tackle challenging disorders.

Latest Patents: Marc Adler's latest patents revolve around therapeutic compounds and their applications in inhibiting specific proteins involved in various disorders. His inventions include compounds of specific formulas aimed at targeting TAF1 for treating related disorders. Additionally, his patents extend to compounds that inhibit CBP and/or EP300, offering promising solutions for related medical conditions.

Career Highlights: Throughout his career, Marc Adler has made remarkable strides in his field while working at renowned companies such as Genentech, Inc. and Constellation Pharmaceuticals, Inc. His expertise and innovative approach have paved the way for the development of cutting-edge pharmaceutical solutions.

Collaborations: Marc Adler has collaborated closely with esteemed professionals in the industry, including coworkers Terry Crawford and Steven R Magnuson. Together, they have synergized their skills and knowledge to drive forward impactful research and development initiatives.

Conclusion: Marc Adler's innovative work in the realm of therapeutic compounds underscores his commitment to advancing healthcare through novel inventions. His patents and contributions stand as a testament to his dedication and expertise in pioneering new treatments for challenging disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…